MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
MBX Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$52.48+2.87 (+5.79%)
Close on Oct 19, 2026
- Market cap
- $2.50B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
38 of MBX Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 20, 2026 | Oct 22, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 27, 2026 | Aug 27, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 4, 2026 | Feb 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 11, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2025 | Sep 26, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2025 | Sep 22, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2025 | Sep 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 22, 2025 | Apr 23, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 7, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2025 | Jan 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2024 | Sep 16, 2024 | SEC EDGAR |